NIMC
JAZZ icon

NWQ Investment Management Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

NWQ Investment Management Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,642
Closed -$623 – 163
2020
Q2 		$623 Buy
+5,642
New +$624K 0.02% 145
2015
Q4 		– Sell
-123,720
Closed -$16.4M – 157
2015
Q3 		$16.4M Sell
123,720
-2,960
-2% -$510K 0.25% 100
2015
Q2 		$22.3M Buy
126,680
+61,856
+95% +$11.1M 0.31% 93
2015
Q1 		$11.2M Buy
64,824
+41
+0.1% +$7.04K 0.14% 103
2014
Q4 		$10.6M Sell
64,783
-73,922
-53% -$12.3M 0.13% 107
2014
Q3 		$22.3M Sell
138,705
-68,219
-33% -$10.5M 0.24% 93
2014
Q2 		$30.4M Buy
206,924
+33,005
+19% +$4.58M 0.31% 76
2014
Q1 		$24.1M Buy
173,919
+36,765
+27% +$5.53M 0.21% 86
2013
Q4 		$17.4M Sell
137,154
-56,079
-29% -$5.8M 0.15% 94
2013
Q3 		$17.8M Sell
193,233
-5,446
-3% -$439K 0.17% 78
2013
Q2 		$13.7M Buy
+198,679
New +$12.1M 0.12% 80

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

NWQ Investment Management Company's JAZZ Position: Q3 2020 in Review

NWQ Investment Management Company sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2020, closing a stake of 5,642 shares — an estimated $623 sold.

NWQ Investment Management Company first reported a position in JAZZ in Q2 2013 and held it in 11 quarters. The position peaked at $30.4M in Q2 2014. 390 funds tracked by Wall St. Rank hold JAZZ as of Q3 2020.

  • NWQ Investment Management Company reported no remaining Jazz Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • NWQ Investment Management Company sold 5,642 Jazz Pharmaceuticals shares in Q3 2020, an estimated $623.
  • NWQ Investment Management Company first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • NWQ Investment Management Company's Jazz Pharmaceuticals position peaked at $30.4M in Q2 2014.
  • 390 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.